Effects of Deep Touch Pressure on Emergence Agitation in Pediatric Patients
The goal of this clinical trial is to determine if deep touch pressure (DTP) can reduce emergence agitation (EA) in pediatric patients aged 3 to 10 years undergoing tonsillectomy and adenoidectomy under general anesthesia. The main questions it aims to answer are: Does deep touch pressure (DTP) using a compression vest
| Condition(s) | Deep Touch Pressure |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to determine if deep touch pressure (DTP) can reduce emergence agitation (EA) in pediatric patients aged 3 to 10 years undergoing tonsillectomy and adenoidectomy under general anesthesia. The main questions it aims to answer are: Does deep touch pressure (DTP) using a compression vest reduce the incidence of emergence agitation (EA) in the recovery room? Does DTP reduce the severity of EA, as measured by the Pediatric Assessment of Emergence Delirium (PAED) scale? Researchers will compare: Intervention Group: Pediatric patients who receive DTP using the HUGgy compression vest during the recovery period. Control Group: Pediatric patients who receive standard postoperative care without DTP. Participants will: Be randomly assigned to either the intervention |
| Who can participate | Inclusion Criteria: * Pediatric patients aged 3 to 10 years scheduled for tonsillectomy and adenoidectomy under general anesthesia. Exclusion Criteria: * Emergency surgery. * Known neurological disorders (e.g., epilepsy, cerebral palsy). * Skin disorders or injuries on the chest or upper body that prevent safe use of the compression vest (HUGgy). * History of severe psychiatric disorders (e.g., autism spectrum disorder, severe anxiety disorder). * History of severe allergic reactions to anesthesia. * Any condition that, in the investigator's judgment, makes the patient unsuitable for the study. |
| Ages | 3 Years to 10 Years |
| Sex | All |
| Lead sponsor | Seoul National University Hospital |
| Locations | Seoul, Seoul, South Korea |
| Start date | 2025-09-04 |
| NCT ID | NCT06966466 |
| Official listing | https://clinicaltrials.gov/study/NCT06966466 |